Patents by Inventor Tania Azam

Tania Azam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of proinsulin for immune system modulation
    Patent number: 9669073
    Abstract: The present disclosure relates to a composition for promoting immune activity including a protein selected from the group consisting of dimeric proinsulin, C-peptide partially deleted mutant of dimeric proinsulin, and C-peptide partially deleted mutant of monomeric proinsulin as an effective component and a composition for immunosuppression including C-peptide site of proinsulin as an effective component, and the dimeric proinsulin, the C-peptide partially deleted mutant of dimeric proinsulin, and the C-peptide partially deleted mutant of monomeric proinsulin can be applied as immune enhancers to diabetic patients.
    Type: Grant
    Filed: March 31, 2015
    Date of Patent: June 6, 2017
    Assignee: Konkuk University Industrial Cooperation Corporation
    Inventors: Soohyun Kim, Si-Young Lee, Eunsom Kim, Seunghyun Jo, Youngmin Lee, Tania Azam, Suyoung Bae, Areum Kwak, Jaewoo Hong, Hyun Jhung Jhun, Jong Ho Lee, Jungmin Lee, Sulah Youn, Busun Kim
  • USE OF PROINSULIN FOR IMMUNE SYSTEM MODULATION
    Publication number: 20160184402
    Abstract: The present disclosure relates to a composition for promoting immune activity including a protein selected from the group consisting of dimeric proinsulin, C-peptide partially deleted mutant of dimeric proinsulin, and C-peptide partially deleted mutant of monomeric proinsulin as an effective component and a composition for immunosuppression including C-peptide site of proinsulin as an effective component, and the dimeric proinsulin, the C-peptide partially deleted mutant of dimeric proinsulin, and the C-peptide partially deleted mutant of monomeric proinsulin can be applied as immune enhancers to diabetic patients.
    Type: Application
    Filed: March 31, 2015
    Publication date: June 30, 2016
    Inventors: Soohyun Kim, Si-Young Lee, Eunsom Kim, Seunghyun Jo, Youngmin Lee, Tania Azam, Suyoung Bae, Areum Kwak, Jaewoo Hong, Hyun Jhung Jhun, Jong Ho Lee, Jungmin Lee, Sulah Youn, Busun Kim
  • Compositions And Methods For Regulation Of Tumor Necrosis Factor-Alpha
    Publication number: 20140235829
    Abstract: The present invention relates to compositions and methods relating to an interleukin 18-inducible cytokine termed tumor necrosis factor-alpha inducing factor (TAIF) or interleukin-32 (IL-32). In particular, the present invention provides compositions and methods for treating autoimmune diseases and cancer, in part by regulation of tumor necrosis factor-alpha expression.
    Type: Application
    Filed: March 17, 2014
    Publication date: August 21, 2014
    Inventors: Soo-Hyun Kim, Charles A. Dinarello, Tania Azam
  • Compositions And Methods For Regulation Of Tumor Necrosis Factor-Alpha
    Publication number: 20120183601
    Abstract: The present invention relates to compositions and methods relating to an interleukin18-inducible cytokine termed tumor necrosis factor-alpha inducing factor (TAIF) or interleukin-32 (IL-32). In particular, the present invention provides compositions and methods for treating autoimmune diseases and cancer, in part by regulation of tumor necrosis factor-alpha expression.
    Type: Application
    Filed: January 19, 2012
    Publication date: July 19, 2012
    Inventors: Soo-Hyun Kim, Charles A. Dinarello, Tania Azam
  • Compositions for regulation of tumor necrosis factor-alpha
    Patent number: 8138312
    Abstract: The present invention relates to compositions and methods relating to an interleukin18-inducible cytokine termed tumor necrosis factor-alpha inducing factor (TAIF) or interleukin-32 (IL-32). In particular, the present invention provides compositions and methods for treating autoimmune diseases and cancer, in part by regulation of tumor necrosis factor-alpha expression.
    Type: Grant
    Filed: June 11, 2009
    Date of Patent: March 20, 2012
    Assignee: The Regents of the University of Colorado, a body corporate
    Inventors: Soo-Hyun Kim, Charles A. Dinarello, Tania Azam
  • Compositions And Methods For Regulation Of Tumor Necrosis Factor-Alpha
    Publication number: 20110190476
    Abstract: The present invention relates to compositions and methods relating to an interleukin18-inducible cytokine termed tumor necrosis factor-alpha inducing factor (TAIF) or interleukin-32 (IL-32). In particular, the present invention provides compositions and methods for treating autoimmune diseases and cancer, in part by regulation of tumor necrosis factor-alpha expression.
    Type: Application
    Filed: June 11, 2009
    Publication date: August 4, 2011
    Inventors: Soo Hyun Kim, Charles A. Dinarello, Tania Azam
  • Compositions for regulation of tumor necrosis factor-alpha
    Patent number: 7560265
    Abstract: The present invention relates to compositions relating a nucleic acid encoding an interleukin 18-inducible cytokine termed tumor necrosis factor-alpha inducing factor (TAIF) or interleukin-32 (IL-32). In particular, the present invention provides vectors for expressing proteins useful for treating autoimmune diseases and cancer, in part by regulation of tumor necrosis factor-alpha expression.
    Type: Grant
    Filed: November 12, 2004
    Date of Patent: July 14, 2009
    Assignee: The Regents of the University of Colorado, a body corporate
    Inventors: Soo-Hyun Kim, Charles A. Dinarello, Tania Azam
  • Compositions and methods for regulation of tumor necrosis factor-alpha
    Publication number: 20070071719
    Abstract: The present invention relates to compositions and methods relating to an interleukin18-inducible cytokine termed tumor necrosis factor-alpha inducing factor (TAIF) or interleukin-32 (IL-32). In particular, the present invention provides compositions and methods for treating autoimmune diseases and cancer, in part by regulation of tumor necrosis factor-alpha expression.
    Type: Application
    Filed: November 12, 2004
    Publication date: March 29, 2007
    Applicant: The Regents of the University of Colorado, a body corporate
    Inventors: Soo-Hyun Kim, Charles Dinarello, Tania Azam